The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Written Description in the Life Sciences after Amgen v. Sanofi" on December 12, 2017 from 2:00 to 3:00 pm (ET).  Jane Love of Gibson, Dunn & Crutcher LLP, Duane Marks of Eli Lilly & Company, and Irena Royzman of Patterson Belknap Webb & Tyler LLP will discuss:

• What is now needed by way of written description to create a valid patent on an antibody? The entire DNA sequence? Just the CDRs?  The entire 3D structure?
• How does Amgen v. Sanofi clarify the law beyond earlier cases such as AbbVie v. Janssen and Ariad v. Lilly?
• How will pharma litigation change after Amgen v. Sanofi, and how will it affect specific pending cases including challenges on Amgen's Embrel®?

The registration fee for the webinar is $135 (government and academic rates are available upon request).  Those interested in registering for the webinar can do so here.